Bruce Arnold Nault, BS | |
165 N State St, Concord, NH 03301-5015 | |
(603) 223-6717 | |
Not Available |
Full Name | Bruce Arnold Nault |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 165 N State St, Concord, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679892319 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 1841 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bruce Arnold Nault, BS 122 King Rd, Chichester, NH 03258-6535 Ph: (603) 798-3715 | Bruce Arnold Nault, BS 165 N State St, Concord, NH 03301-5015 Ph: (603) 223-6717 |
News Archive
The first worldwide study of the societal impact of endometriosis has found a significant loss of work productivity among those women who suffer from the condition, a researcher told the 26th annual meeting of the European Society of Human Reproduction and Embryology today (Monday).
Vermillion, Inc., a molecular diagnostics company, today announced that it is relocating its corporate headquarters from Fremont, California to Austin, Texas. Vermillion has executed a two-year lease for a new principal place of business at 12117 Bee Cave Road, Building Two, Suite 100, Austin, TX 78731. Vermillion will continue to operate research and development, regulatory and quality operations in California. All other functions will be conducted at the Austin offices.
A controversial surgical procedure that has lost favor among medical professionals may benefit women who have had caesarean sections. So say researchers at the Stanford University School of Medicine, who have found that closing the parietal peritoneum, a multi-layered membrane that lines the abdomino-pelvic walls, substantially decreases the likelihood of scarring that can make future C-sections more difficult.
Dyax Corp. today announced the pricing of an underwritten public offering of 17,000,000 shares of its common stock at a price to the public of $3.25 per share. The gross proceeds from the sale of shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $51.8 million. The offering is expected to close on or about March 30, 2010, subject to customary closing conditions.
› Verified 8 days ago
Mr. Richard Jon Tripp, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-225-2711 | |
Mr. John Michael Tracy Sr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 Locke Rd, Suite 3, Concord, NH 03301 Phone: 603-223-0380 Fax: 603-223-0347 | |
Mary Kate Langlais-mcnutt, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 92 South St, Concord, NH 03301 Phone: 603-228-8400 | |
Mr. John Christopher Wakelin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Main St, Concord, NH 03301 Phone: 603-224-9591 Fax: 603-224-5361 | |
Joseph Pirani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Granite Pl Ste N200, Concord, NH 03301 Phone: 603-226-8686 | |
Mrs. Ann Marie Bisson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Main St, Concord, NH 03301 Phone: 603-224-9591 | |
Mr. Khiem D Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Hall St, Concord, NH 03103 Phone: 603-623-3532 |